V710

BIOLOGICAL3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

BacteremiaMediastinitisStaphylococcal InfectionStaphylococcal InfectionsStaphylococcus Aureus

Phase 1

V710 First-In-Man (FIM) Study (V710-001)

CompletedNCT00303069

Merck Sharp & Dohme LLCStaphylococcal Infections

Start: 2005-11-30End: 2006-07-31Updated: 2015-07-22

V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)

CompletedNCT00735839

Merck Sharp & Dohme LLCStaphylococcal Infection

Start: 2008-03-31End: 2008-06-30Updated: 2015-12-21

Phase 2

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

TerminatedNCT00518687

Merck Sharp & Dohme LLCBacteremia, Mediastinitis, Staphylococcus Aureus

Start: 2007-12-31End: 2011-08-31Updated: 2015-10-02

Related Papers

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

2013-04-01284 citations